Table 1.
Descriptiona | Age of study participants at each visit | ||||||||
---|---|---|---|---|---|---|---|---|---|
6 months | 12 months | 18 months | |||||||
HUU | HEU | p* | HUU | HEU | p | HUU | HEU | p | |
Demographic data | |||||||||
Number of children per visit | 31 | 33 | – | 29 | 31 | – | 28 | 30 | – |
Females (%) | 65 | 46 | – | 62 | 42 | – | 64 | 40 | – |
Laboratory parameters | |||||||||
WBC count, ×103 cells/ml | 10.2 | 9.45 | 0.51 | 11.5 | 12.0 | 0.65 | 9.5 | 8.4 | 0.34 |
Total CD4 T cells (%) | 58.4 | 55.2 | 0.042 | 51.1 | 54.8 | 0.62 | 48.8 | 54.8 | 0.052 |
Mothers health status | |||||||||
Mother on ART, % | – | 97 | – | – | 100 | – | – | 97 | – |
Mother on CTX, % | – | 100 | – | – | 100 | – | – | 100 | – |
p p value, WBC white blood cells, ART antiretroviral therapy, CTX cotrimoxazole
* p value obtained with Mann–Whitney U test, p value of <0.05 was considered significant
aPresented as medians